Delivery Order SPE2DB22D3501-SPE2DB24FUG78

Award Date 1/23/24
Potential Completion Date 1/24/24
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,685.10 Firm Fixed Price Delivery Order is for the supply of Dexamethasone 10 mg/ml vials. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,280.12 firm fixed-price delivery order is for the supply of 10 mg/mL vials of the medication dexamethasone. The contract has an ultimate completion date of May 19, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,524.24, is a Firm Fixed Price Delivery Order for the supply of Dexamethasone 10 mg/ml vials. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,182.24, is for the delivery of 4,566,189,769 milliliters of dexamethasone 10 mg/mL vials. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,059.75, is for the delivery of 4,565,815,786 units of Dexamethasone 20 mg/5 ml vials. This is a firm-fixed price delivery order contract with a completion date of September 17, 2024. The contract is not set-aside. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $7,092.66 for the supply of 4,556,652,126 units of Dexamethasone 20 mg/5 ml vials. The award was made by the Defense Logistics Agency (DLA), a defense agency, on March 22, 2022, with a final completion date of March 23, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award, with a ceiling value of $2,113.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,190 units of dexamethasone 4 mg tablets, a medication used to treat various conditions. The contract is a Firm Fixed Price Delivery Order, with a performance period extending through May 9, 2025. The contract is not set aside for any...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of dexamethasone 20 mg/5 ml vial, a critical pharmaceutical product. The $2,376.00 firm-fixed-price contract has a performance period through September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXAMETHASONE 4 MG TABLET 100S. The contract has a ceiling value of $1,011.00 and is a firm fixed price award from the Defense Logistics Agency, a defense agency. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,095.97 firm fixed-price delivery order has an ultimate completion date of August 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. government, holding several Indefinite Delivery Contracts (IDCs) with...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FUG78
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dexamethasone 10 mg/mL vials. The fixed-price delivery order, valued at $2,176.66, has a period of performance through January 24, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was made without any set-aside designation, indicating it was competed on a full and open basis.

Generated 5/13/25, 9:58 AM